K Number
K122831
Date Cleared
2012-12-14

(88 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

This video system center is intended to be used with OLYMPUS video converter, camera heads, endoscopes, monitors, EndoTherapy accessories, and other ancillary equipment for endoscopic diagnosis, treatment, and video observation.

Device Description

The VIDEO SYSTEM CENTER OLYMPUS CV-170 is intended for endoscopic diagnosis, treatment and video observation. The CV-170 is a device which integrates the video processor and the light source. Thus, the CV-170 itself could emit light, capture and process the endoscopic image, and transmit signal to display it on the monitor. The main function of the CV-170 is NBI observation, LED lamp examination, Noise reduction function, Pre-freeze feature, and Color correction.

AI/ML Overview

This document is a 510(k) Summary for the Olympus CV-170 Video System Center. It describes the device, its intended use, and compares it to predicate devices. However, this document does not contain the results of a primary clinical study with acceptance criteria, reported device performance, or details about ground truth establishment.

Instead, this document, typical for a 510(k) submission, focuses on demonstrating substantial equivalence to a legally marketed predicate device (OLYMPUS CV-190 VIDEO SYSTEM CENTER and OLYMPUS CLV-190 XENON LIGHT SOURCE, K112680). The "Summary of non-clinical testing" section mentions:

  • "Risk analysis was carried out in accordance with established in-house acceptance criteria based on ISO 14971:2007. The design verifications tests and their acceptance criteria were identified and performed as a result of this risk analysis assessment."
  • "The software validation activities were performed in accordance with the FDA Guidance, 'Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices.'"

This indicates that internal design verification and software validation tests were performed against in-house acceptance criteria to ensure the device's safety and effectiveness compared to the predicate, but the specific details of these acceptance criteria and performance results are not included in this summary.

Therefore, I cannot provide the requested information in the format you specified because it is not present in the provided text. The document states that non-clinical testing was performed, focusing on risk analysis, design verification, and software validation. It does not describe a study involving human readers or the evaluation of an AI algorithm against clinical ground truth.

Specifically, the questions that cannot be answered from the provided text are:

  1. A table of acceptance criteria and the reported device performance: The document states that internal acceptance criteria were used for risk analysis and design verification, but it does not list them or the specific performance results in a table.
  2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective): No test set sample size or data provenance is mentioned as there's no clinical performance study reported.
  3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience): No ground truth establishment is described for a test set.
  4. Adjudication method (e.g. 2+1, 3+1, none) for the test set: No adjudication method is described.
  5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: No MRMC study or AI assistance is mentioned. This device is a video system center, not an AI-driven diagnostic tool.
  6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: No standalone algorithm performance is mentioned.
  7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): No ground truth type is mentioned.
  8. The sample size for the training set: No training set or sample size is mentioned.
  9. How the ground truth for the training set was established: No ground truth establishment for a training set is mentioned.

{0}------------------------------------------------

K122831 Page 1 of 3

Image /page/0/Picture/1 description: The image shows the text "510(k) SUMMARY" in bold, black font. The text is centered and appears to be the title or heading of a document. The letters are capitalized and evenly spaced.

DEC 1 4 2012

CV-170 VIDEO SYSTEM CENTER

September 14, 2012

General Information 1.

Applicant:

1

Official Correspondent:

. Manufacturer: OLYMPUS MEDICAL SYSTEMS CORP. 2951 Ishikawa-cho, Hachioji-shi, Tokyo, Japan 192-8507 Establishment Registration No: 8010047

Sheri L. Musgnung Associate Manager, Regulatory Affairs Olympus America Inc. 3500 Corporate Parkway PO Box 610 Center Valley, PA 18034-0610, USA Phone: 484-896-3147 FAX: 484-896-7128 Email: sheri.musgnung@olympus.com

SHIRAKAWA OLYMPUS CO., LTD. 3-1 Aza-Ookamiyama, Ooaza-Odakura, Nishigo-mura, Nishishirakawa-gun, Fukushima, Japan 961-8061 Establishment Registration No: 3002808148

II. Device Identification

  • 1 Device Trade Name: CV-170 VIDEO SYSTEM CENTER
  • . VIDEO SYSTEM CENTER Common Name:
  • 1 Regulation Number: 876.1500
  • . Regulation Name: Endoscope and Accessories

==============================================================================================================================================================================

  • 0 Regulatory Class:
    • Classification Panel: Gastroenterology and urology

Product Code:

1

NTN (led light source) NWB (endoscope, accessories, band narrow spectrum)

{1}------------------------------------------------

III. Predicate Device Information

Model nameApplicant510(k) No.
OLYMPUS CV-190 VIDEOSYSTEM CENTEROLYMPUS MEDICALSYSTEMS CORP.K112680
OLYMPUS CLV-190 XENONLIGHT SOURCEOLYMPUS MEDICALSYSTEMS CORP.K112680

IV. Device Description

The VIDEO SYSTEM CENTER OLYMPUS CV-170 is intended for endoscopic diagnosis, treatment and video observation.

The CV-170 is a device which integrates the video processor and the light source. Thus, the CV-170 itself could emit light, capture and process the endoscopic image, and transmit signal to display it on the monitor.

The main function of the CV-170 is NBI observation, LED lamp examination, Noise reduction function, Pre-freeze feature, and Color correction.

V. Indications for Use

This video system center is intended to be used with OLYMPUS video camera heads. endoscopes. monitors. converter. EndoTherapv accessories, and other ancillary equipment for endoscopic diagnosis, treatment, and video observation.

VI. Comparison of Technological Characteristics

The main difference of the subject device compared to the predicate devices is the examination lamp type. Unlike the predicate device, CLV-190 XENON LIGHT SOURCE, the subject device utilize LED as the examination lamp.

VII. Summary of non-clinical testing

Risk analysis was carried out in accordance with established in-house acceptance criteria based on ISO 14971:2007. The design verifications tests and their acceptance criteria were identified and performed as a result of this risk analysis assessment.

The software validation activities were performed in accordance with the FDA Guidance, "Guidance for the Content of Premarket Submissions for

{2}------------------------------------------------

Software Contained in Medical Devices." The device software is considered a MODERATE Level of Concern.

The following standards have been applied to the CV-170:

  • · IEC 60601-1
  • · IEC 60601-1-1
  • · IEC 60601-2-18
  • · IEC 60601-1-2
  • · ISO 14971

VIII. Conclusion

When compared to the predicate device, the CV-170 VIDEO SYSTEM CENTER does not incorporate any significant changes in intended use, method of operation, or design that could affect the safety or effectiveness of the device.

{3}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" arranged around the perimeter. Inside the circle is a stylized graphic of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

December 14, 2012

OL YMPUS MEDICAL SYSTEMS CORP. % Ms. Sheri L. Musgnung Associate Manager, Regulatory Affairs Olympus America, Inc. 3500 Corporate Parkway, P.O. Box 610 CENTER VALLEY PA 18034-0610

Re: K122831

Trade/Device Name: CV-170 VIDEO SYSTEM CENTER Regulation Number: 21 CFR§ 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: NTN, NWB, FET Dated: September 14, 2012 Received: September 17, 2012

Dear Ms. Musgnung:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

{4}------------------------------------------------

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Herbert R. Lerner

for

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use

510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

. 510(k) Number (if known):

Device Name: CV-170 VIDEO SYSTEM CENTER

Indications For Use:

This video system center is intended to be used with OLYMPUS video converter, camera heads, endoscopes, monitors, EndoTherapy accessories, and other ancillary equipment for endoscopic diagnosis, treatment, and video observation.

Prescription Use_ (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

Page 1 of

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Herbert R. Lerner

(Division Sign-Off)
Division of Reproductive, Gastro-Renal, and
Urological Devices
510(k) Number K122831

12

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.